Related Experiment Video
Updated: May 15, 2026
05:18
A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes
Published on: February 17, 2023
Embelin accelerates cutaneous wound healing in diabetic rats
Pradeep T Deshmukh1, Vipin B Gupta
1Department of Pharmacology, Faculty of Pharmaceutical Sciences, Jodhpur National University, Narnadi, Bornada, Jodhpur, Rajasthan, India. pradipdeshmukh@gmail.com
Journal of Asian Natural Products Research
|January 19, 2013
Summary
Embelin significantly accelerates wound healing in diabetic rats. Topical and oral embelin improved wound contraction, epithelialization, and tissue repair in various wound models, demonstrating its therapeutic potential.
Area of Science:
- Pharmacology
- Wound Healing Research
- Diabetic Complications
Background:
- Diabetes mellitus impairs wound healing, leading to chronic non-healing wounds.
- Diabetic complications often involve delayed tissue repair and increased infection risk.
- Novel therapeutic agents are needed to enhance wound healing in diabetic patients.
Purpose of the Study:
- To investigate the efficacy of embelin in promoting cutaneous wound healing in streptozotocin (STZ)-induced diabetic rats.
- To evaluate the effects of embelin on different wound models, including excision, incision, and dead space wounds.
- To assess the biochemical and biomechanical parameters of wound healing following embelin treatment.
Main Methods:
- Induction of diabetes in rats using streptozotocin (STZ).
- Application of embelin (5% ointment, topical; 25 and 50 mg/kg, oral) to various cutaneous wound models.
- Measurement of wound contraction, epithelialization, hydroxyproline, hexosamine, total protein, and DNA content.
- Assessment of wound breaking strength and granuloma tissue weight.
Main Results:
- Topical embelin significantly enhanced wound contraction and epithelialization in diabetic rats.
- Both topical and oral embelin increased hydroxyproline, hexosamine, total protein, and DNA content in granulation tissue.
- Embelin administration led to a significant increase in wound breaking strength and granuloma tissue weight.
Conclusions:
- Embelin demonstrates significant wound healing properties in STZ-induced diabetic rats.
- The compound accelerates healing through improved tissue regeneration and biomechanical strength.
- Embelin holds potential as a therapeutic agent for managing diabetic wound complications.
Related Concept Videos
01:31Diabetic Foot Ulcer
Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory neuropathy reduces pain perception,...
01:19Clinical Applications of Epidermal Stem Cells
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...